drug

cabotegravir

1 story · latest Aug 26, 2026

Status: FDA approved Jan 2021 · NDA212887, NDA215499
Brands: Apretude, Vocabria
Trials: 4 registered trials in coverage

Relationships

Developed by GlaxoSmithKline

Also known as

cabotegravir sodium

Timeline

NIAID-led IMPAACT 2026 pharmacokinetic study terminated early, results posted

Aug 26Trial updateGilead Sciences GlaxoSmithKline

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.